Esperion Therapeutics
ESPR
ESPR
175 hedge funds and large institutions have $304M invested in Esperion Therapeutics in 2024 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 49 increasing their positions, 26 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
4.47% more ownership
Funds ownership: 67.71% → 72.18% (+4.5%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
10% less capital invested
Capital invested by funds: $336M → $304M (-$32.1M)
Holders
175
Holding in Top 10
2
Calls
$7.09M
Puts
$3.5M
Top Buyers
| 1 | +$24.7M | |
| 2 | +$17.2M | |
| 3 | +$7.11M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$5.34M |
| 5 |
WCM
Whitefort Capital Management
New York
|
+$5.1M |
Top Sellers
| 1 | -$36.7M | |
| 2 | -$10.6M | |
| 3 | -$7.51M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$6.38M |
| 5 |
Goldman Sachs
New York
|
-$5.44M |